Case report: An unusual case of adrenal neuroblastoma in pregnancy

Oncologist

Volumn 13, Issue 2, 2008, Pages 152-156

  Refaat, Marwan M ^a   Idriss, Shereene Z ^a   Blaszkowsky, Lawrence S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adrenal; Adult; Neuroblastoma; Pregnancy

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE;

ABDOMINAL PAIN; ADRENAL NEUROBLASTOMA; ADRENALECTOMY; ADULT; ARTICLE; BONE MARROW EXAMINATION; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHORIOAMNIONITIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENTALOMA; METASTASIS; NECROSIS; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PRIORITY JOURNAL; RARE DISEASE; SPONTANEOUS ABORTION; TUMOR RECURRENCE; ULTRASOUND; URINALYSIS; URINE LEVEL; VAGINA BLEEDING;

ABORTION, SPONTANEOUS; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; CHORIOAMNIONITIS; FEMALE; HUMANS; NEOPLASM STAGING; NEUROBLASTOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY TRIMESTER, FIRST; RISK FACTORS;

EID: 40349093044     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2006-0180     Document Type: Article

References (25)

1. Kushner BH, Cheung NK. Neuroblastoma - from genetic profiles to clinical challenge. N Engl J Med 2005;353:2215-2217.
2. Yamamoto K, Hanada R, Kikuchi A et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 1998;16:1265-1269.
3. Koontz SE. Common pediatric cancers. US Pharmacist 2004;10(onc suppl):4-10.
4. Koch CA, Brouwers FM, Rosenblatt K et al. Adrenal ganglioneuromas in a patient presenting with severe hypertension and diarrhea. Endocr Relat Cancer 2003;10:99-107.
5. Weinstein JL, Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. The Oncologist 2003;8:278-292.
6. Triche TJ, Askin FB. Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors. Hum Pathol 1983;14:569-595.
7. Rubie H, Hartmann O, Michon J et al. N-myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique. J Clin Oncol 1997;15:1171-1182.
8. Shimada H, Ambros IM, Dehner LP et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999;86:364-372.
9. Brodeur GM, Pritchard J, Berthold F et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-1477.
10. Woods WG, Gao RN, Shuster JJ et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002;346:1041-1046.
11. Franks LM, Bollen A, Seeger RC et al. Neuroblastoma in adults and adolescents: An indolent course with poor survival. Cancer 1997;79:2028-2035.
12. Gaspar N, Hartmann O, Munzer C et al. Neuroblastoma in adolescents. Cancer 2003;98:349-355.
13. Rubie H, Coze C, Plantaz D et al. Localised and unresectable neuroblastoma in infants: Excellent outcome with low-dose primary chemotherapy. Br J Cancer 2003;89:1605-1609.
14. Rubie H, Plantaz D, Coze C et al. Localised and unresectable neuroblastoma in infants: Excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique. Med Pediatr Oncol 2001;36:247-250.
15. Leclair MD, Hartmann O, Heloury Y et al. Localized pelvic neuroblastoma: Excellent survival and low morbidity with tailored therapy - the 10-year experience of the French Society of Pediatric Oncology. J Clin Oncol 2004;22:1689-1695.
16. Katzenstein HM, Bowman LC, Brodeur GM et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The pediatric oncology group experience - a Pediatric Oncology Group study J Clin Oncol 1998;16:2007-2017.
17. Nickerson HJ, Matthay KK, Seeger RC et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study. J Clin Oncol 2000;18:477-486.
18. Simon T, Spitz R, Faldum A et al. New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status. J Pediatr Hematol Oncol 2004;26:791-796.
19. Brodeur GM, Maris JM. Neuroblastoma. In: Principles and Practice of Pediatric Oncology. Pizzo PA, Poplack DG, eds). Philadelphia: Lippincott Williams & Wilkins, 2002:895-938.
20. Matthay KK, Villablanca JG, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-1173.
21. Laprie A, Michon J, Hartmann O et al. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system stage II and III neuroblastoma with MYCN amplification. Cancer 2004;101:1081-1089.
22. Haas-Kogan DA, Swift PS, Selch M et al. Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study. Int J Radiat Oncol Biol Phys 2003;56:28-39.
23. Marcus KJ, Shamberger R, Litman H et al. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol 2003;25:934-940.
24. Rowe PH, Oram JJ, Scott GW. Neuroblastoma in adults. Postgrad Med J 1979;55:579-580.
25. Perez CA, Matthay KK, Atkinson JB et al. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: A Children's Cancer Group study. J Clin Oncol 2000;18:18-26.